| Followers | 178 |
| Posts | 16783 |
| Boards Moderated | 0 |
| Alias Born | 11/10/2008 |
Monday, September 27, 2021 9:32:02 AM
Yes. But why can't I believe it?
By the way, what other option do we have to 'choose' other than to take what ever (I will believe .002 when I see it, until then....) they end up pushing our way.
Sure, the SEC may be requiring substantial paperwork (which would not surprise me given how paperwork is the only way they can justify their existence) but the delay in getting the payout has gone on far too long for me to think anything other than the worse.
I still think we have been 'had' and Management is just trying to emerge from all the stink they left behind by offering tons of excuses on why 'extenuating circumstances' they have no control over resulted in the final determination and best equitable resolve. Free and clear. Faultless. Bye.
See. I too can prepare myself for an unfavorable result. Keep my expectation VERY LOW.
By the way, what other option do we have to 'choose' other than to take what ever (I will believe .002 when I see it, until then....) they end up pushing our way.
Sure, the SEC may be requiring substantial paperwork (which would not surprise me given how paperwork is the only way they can justify their existence) but the delay in getting the payout has gone on far too long for me to think anything other than the worse.
I still think we have been 'had' and Management is just trying to emerge from all the stink they left behind by offering tons of excuses on why 'extenuating circumstances' they have no control over resulted in the final determination and best equitable resolve. Free and clear. Faultless. Bye.
See. I too can prepare myself for an unfavorable result. Keep my expectation VERY LOW.
Recent RMTG News
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 04/01/2026 03:48:57 PM
- RMTG Subsidiary Cellgenic Commences Full-Scale Manufacturing at First-of-Its-Kind • ACCESS Newswire • 03/26/2026 11:55:00 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/19/2025 10:12:56 PM
- RMTG Subsidiary CELLGENIC Introduces Peptide Pen Product Line at Cancún Global Summit • ACCESS Newswire • 11/18/2025 12:59:00 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/14/2025 09:59:17 PM
- RMTG Subsidiary CELLGENIC Expands into Dominican Republic with New Distribution Partnership • ACCESS Newswire • 10/21/2025 11:59:00 AM
- RMTG Expands into Brazil with Strategic Representation Agreement • ACCESS Newswire • 10/14/2025 11:59:00 AM
- RMTG's ISSCA Regenerative Medicine Global Summit 2025 Concludes in Cancún with Full Attendance from 30+ Countries • ACCESS Newswire • 10/08/2025 11:59:00 AM
- RMTG Partners with BKFC as Official Regenerative Medicine Provider • ACCESS Newswire • 09/29/2025 12:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/19/2025 08:32:41 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 08/13/2025 08:06:31 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 06/30/2025 04:15:10 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 06/12/2025 01:56:55 AM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 05/14/2025 08:33:15 PM
